Table 4 Median test analyses of the SARS-CoV-2-R-A titers in BAU/mL at different serological time point assessments according to occurrence of breakthrough SARS-CoV-2 infectiona.

From: One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

Variables

SARS-CoV-2 infection

No infection

P-value

SARS-CoV-2-R-A at 3–6 weeks (n = 1250)

229

1021

 

• Median Ab titers in BAU/mL (range)

202 (0–10400)

937 (0–56800)

<0.001

SARS-CoV-2-R-A at 3 months (n = 910)

136

774

 

• Median Ab titers in BAU/mL (range)

64.9 (0–5714)

380 (0–30460)

<0.001

SARS-CoV-2-R-A at 6 months (n = 841)

144

697

 

• Median Ab titers in BAU/mL (range)

302 (0–48842)

897.35 (0–95334)

<0.001

SARS-CoV-2-R-A at 12 months (n = 674)

36

638

 

• Median Ab titers in BAU/mL (range)

1017 (0–6423)

2080 (0–87200)

0.003

  1. SARS-CoV-2-R-A SARS-CoV-2 reactive antibodies, Ab antibodies.
  2. aResults of median test remain unchanged when we only include evaluable cases for Omicron VOC.
Back to article page